Interestingly, Van Hemelrijck et al. found no association between serum haptoglobin levels and prostate cancer risk, whereas Arthur et al. reported an association of higher haptoglobin levels with increased risk of metastatic prostate cancer, but not with prostate cancer death or overall death16,17. The gene discussed is HP; the disease is metastatic prostate carcinoma.